| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 07/15/2010 | US20100178676 Methods for antibody production |
| 07/15/2010 | US20100178675 System for extracting protein from a fermentation product |
| 07/15/2010 | US20100178674 Recovery and purification of b-phycoerythrin produced by porphyridium cruentum using two-aqueous-phase systems and isoelectric precipitation |
| 07/15/2010 | US20100178673 Methods of Gene Amplification and Expression |
| 07/15/2010 | US20100178672 Cho cell |
| 07/15/2010 | US20100178671 Vector constructs and methods for expressing and secreting polypeptides in filamentous fungi using a self-processing 2a cleavage site |
| 07/15/2010 | US20100178296 Antibodies to cd200r |
| 07/15/2010 | CA2747192A1 Compositions and methods to prevent cancer with cupredoxins |
| 07/14/2010 | EP2206788A1 Recombinant microorganism |
| 07/14/2010 | EP2206787A2 Peptide-enhanced transfections |
| 07/14/2010 | EP2206785A1 Improved expression of HIV polypeptides and production of virus-like particles |
| 07/14/2010 | CN101778943A Protein production in plants |
| 07/14/2010 | CN101775429A Whey protein antioxidant peptides, preparation method thereof and application thereof |
| 07/14/2010 | CN101775428A Biomass pretreatment method |
| 07/14/2010 | CN101775427A Method for regulating microorganism metabolism lipopeptid compound composition |
| 07/14/2010 | CN101775426A Production method of casein by lipase method |
| 07/14/2010 | CN101775406A Recombinant protein expression and purification with functions of preventing and treating atherosclerosis |
| 07/14/2010 | CN101775387A Mesoporous titanium dioxide immobilized enzyme and preparation method and application thereof |
| 07/14/2010 | CN101775068A Novel natural antibacterial peptides, and coding sequence and uses thereof |
| 07/13/2010 | US7754868 stress-related fusion proteins, antigenic peptides, and anti-stress-related antibodies; nucleic acid molecule encodes polypeptide which increases bile tolerance of cell; Lactobacillus acidophilus cell with an increased ability to survive stressful conditions compared to a wild-type |
| 07/13/2010 | US7754859 Targeted binding agents directed to PDGFR-alpha and uses thereof |
| 07/13/2010 | US7754858 Antibodies to tumor necrosis factor receptor associated factor polypeptides |
| 07/13/2010 | US7754856 Human sodium-dependent bile acid transporter proteins |
| 07/13/2010 | US7754855 comprising a full-length human erythropoietin protein joined without an intervening peptide linker to a human immunoglobulin domain; making fusion proteins comprising a cytokine or growth factor fused to an immunoglobulin domain; treating deficient hematocrit; purification |
| 07/13/2010 | US7754853 Tumor necrosis factors (TNF); site-directed mutagenesis, genetic deletions; monoclonal antibodies with decreased immunogenicity and lymphocyte epitopes; major histocompatibility complex binding ligands; for treatment of rheumatoid arthritis and Crohn's disease |
| 07/13/2010 | US7754682 Blood coagulation factor; nucleotide sequence encodes polypeptide; amino acid sequence differs in 1-15 amino acid residues and comprises an introduced in vivo N-glycosylation site; substitution V253N; coagulation related disorders |
| 07/13/2010 | US7754495 Methods for early diagnosing of an increased risk of preeclampsia |
| 07/13/2010 | US7754470 bioremediation of toxic metals; Chromium (VI) or Uranium (VI) with an effective amount of an E. Coil nitroreductase enzyme (ChrR) polypeptide |
| 07/13/2010 | US7754466 Method for producing dipeptides |
| 07/13/2010 | US7754460 Enzyme for the production of long chain peracid |
| 07/13/2010 | US7754450 combining immunoglobulin-producing donor cells with immunogenic antigen in vitro, fusing cells with myeloma cells to form parental hybridoma cells (which express a dominant negative allele of a mismatch repair gene), incubating to mutate, then screening for antibodies |
| 07/13/2010 | US7754449 Human papilloma virus treatment |
| 07/13/2010 | US7754448 by expression of a nucleic acid encoding NK polypeptide in a microbial host cell, isolating inclusion bodies containing the NK polypeptide in denatured form, solubilization of the inclusion bodies and naturation of the denatured NK polypeptide |
| 07/13/2010 | US7754447 controlling partitioning of a recombinant protein between the supernatant and the periplasm in E. coli host cell cultures wherein expression of the recombinant protein by the cells is under the control of an inducible system |
| 07/13/2010 | US7754418 Immunoglobulin composition for detection of cell death regulatory proteins; diagnosing cardiovascular, tumor, diabetic and nervous system disorders |
| 07/13/2010 | US7754228 Cytotoxic T-cell epitopes from Chlamydia |
| 07/13/2010 | US7754223 Piscirickettsia salmonis antigens and use thereof |
| 07/13/2010 | US7754219 by binding a target antigen (such as a protein) to a transport factor that contains a fragment of a bipartite protein exotoxin, but not the corresponding protective antigen |
| 07/13/2010 | CA2536807C Expression vector |
| 07/13/2010 | CA2474734C Thermostable taq polymerase fragment |
| 07/13/2010 | CA2286895C Plant fatty acid epoxygenase genes and uses therefor |
| 07/13/2010 | CA2286873C Dendritic cell hybrids |
| 07/13/2010 | CA2262893C Peptides responsive to antibodies against a consensus peptide of the cs4-cfa/i family proteins |
| 07/13/2010 | CA2259724C Monoclonal antibody which is specific for activated coagulation factor vii, and its use |
| 07/13/2010 | CA2183564C Methods for altering fertility |
| 07/08/2010 | WO2010078584A1 Cyanobacterium that produces neutral lipids |
| 07/08/2010 | WO2010078462A1 Protein hydrolysate compositions |
| 07/08/2010 | WO2010077775A1 Polypeptides having alpha-mannosidase activity and polynucleotides encoding same |
| 07/08/2010 | WO2010076552A1 Process for production of an enzymatic preparation for hydrolysis of cellulose from lignocellulosic residues and application thereof in the production of ethanol |
| 07/08/2010 | WO2010076361A1 Inclusion bodies, bacterial cells and compositions containing them and uses thereof |
| 07/08/2010 | WO2010075770A1 A recombinant fusion protein, the preparation method and use thereof |
| 07/08/2010 | US20100174054 Compositions of Aminoacyl-tRNA Synthetase and Uses Thereof |
| 07/08/2010 | US20100174050 Expression of polypeptides from the nuclear genome of ostreococcus sp |
| 07/08/2010 | US20100173978 Human mini-antibody cytotoxic for tumor cells which express the erbb2 receptor |
| 07/08/2010 | US20100173842 Vaccine for staphylococcal infections |
| 07/08/2010 | US20100173430 Cysteine-tagged staphylococcal protein g variant |
| 07/08/2010 | US20100173412 Eukaryotic Layered Vector Initiation Systems |
| 07/08/2010 | US20100173389 Process for bacterial production of polypeptides |
| 07/08/2010 | US20100173388 Recombinant poxvirus expressing homologous genes inserted into the poxviral genome |
| 07/08/2010 | US20100173385 highly phosphorylated mannopyranosyl oligosaccharide derivatives containing mannose-6-phosphate (M6P); modified glycoproteins to increase uptake by cell surface receptor-mediated mechanisms, thus improving their therapeutic efficacy in a variety of applications |
| 07/08/2010 | US20100173362 Hepatocyte Growth Factor (HGF) Binding Proteins |
| 07/08/2010 | US20100173361 Hepatocyte Growth Factor (HGF) Binding Proteins |
| 07/08/2010 | US20100173360 Zinc oxide-binding antibody and use thereof |
| 07/08/2010 | US20100173359 Enhanced biotherapeutic production using inhibitory rna |
| 07/08/2010 | US20100173358 Method for obtaining a valuable product, particularly starch, from grain flour |
| 07/08/2010 | US20100173357 Method of making activated carboxypeptidases |
| 07/08/2010 | US20100173324 Anti-cd27 antibody |
| 07/08/2010 | US20100173323 Glycosylation engineered antibody therapy |
| 07/08/2010 | US20100173302 Positive control proteins for glucose transporter proteins and processes for the generation of such positive control proteins |
| 07/08/2010 | US20100173297 Novel serpentine transmembrane antigens expressed in human cancers and uses thereof |
| 07/08/2010 | US20100173286 Mutant Cells Suitable for Recombinant Polypeptide Production |
| 07/08/2010 | US20100172968 Chimeric cannulae proteins and methods for making and using them |
| 07/08/2010 | US20100172938 Modified bacterial surface layer proteins |
| 07/08/2010 | US20100172922 Expression and Purification of HIP/PAP and Uses Therefor |
| 07/08/2010 | US20100172917 Binding molecules against SARS-coronavirus and uses thereof |
| 07/08/2010 | US20100172912 Methods of therapy for b-cell malignancies using antagonist anti-cd40 antibodies |
| 07/08/2010 | US20100172907 Anti-Abeta antibodies and their use |
| 07/08/2010 | US20100172906 Anti-herpes simplex virus antibodies and methods of use thereof |
| 07/08/2010 | US20100172895 Human CGRP Receptor Binding Proteins |
| 07/08/2010 | US20100172894 Methods for purification of single domain antigen binding molecules |
| 07/08/2010 | US20100172888 Hcv-reactive t cell receptors |
| 07/08/2010 | US20100172832 Diagnosis and treatment of malignant neoplasms |
| 07/08/2010 | CA2749067A1 Inclusion bodies, bacterial cells and compositions containing them and their uses |
| 07/08/2010 | CA2748640A1 Zein composition |
| 07/08/2010 | CA2747603A1 Protein hydrolysate compositions |
| 07/08/2010 | CA2746757A1 Polypeptides having alpha-mannosidase activity and polynucleotides encoding same |
| 07/07/2010 | EP2204452A1 Modified Vaccinia Ankara Virus variant |
| 07/07/2010 | EP2204447A2 Method for generating diversity |
| 07/07/2010 | EP2204190A1 IgM production by transformed cells and methods for quantifying said IgM production |
| 07/07/2010 | EP2203558A2 Translocation and mutant ros kinase in human non-small cell lung carcinoma |
| 07/07/2010 | EP1920239B1 Detection and measurement of blood-feeding activity |
| 07/07/2010 | EP1470218B1 Corona-virus-like particles comprising functionally deleted genomes |
| 07/07/2010 | EP1446158B1 Efficient inhibition of hiv-1 viral entry through a novel fusion protein including cd4 |
| 07/07/2010 | EP1334201B1 Dna expression vectors |
| 07/07/2010 | EP1079862B1 Therapeutics using a bispecific anti-hla class ii invariant chain x anti-pathogen antibody |
| 07/07/2010 | CN101772570A Heterologous and homologous cellulase expression system |
| 07/07/2010 | CN101768618A Method for preparing exorphins from soybean protein isolate by fractional hydrolysis |
| 07/07/2010 | CN101768601A Method for producing recombinant human serum albumin-interferon alpha 2b |
| 07/07/2010 | CN101768577A Extraction of lysozyme in egg white and comprehensive utilization of egg white protein |
| 07/07/2010 | CN101768551A Multipole immobilized enzyme film reaction device and method of preparing casein phosphopeptides by using reaction device |